This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Dartmouth College. Active years: 2012-2013.
Company Filing History:
Years Active: 2012-2013
Title: The Innovations of Sergio Quezada
Introduction
Sergio Quezada is a notable inventor based in New York, NY (US). He has made significant contributions to the field of immunology, particularly in the development of regulatory T cell proteins. With a total of 2 patents, his work has the potential to impact therapeutic strategies for immune regulation.
Latest Patents
Quezada's latest patents include groundbreaking inventions related to regulatory T cell mediator proteins and their uses. The first patent describes a novel protein, designated PD-L3, which resembles members of the PD-L1 family and co-stimulates αCD3 proliferation of T cells in vitro. The second patent identifies a TNF-like protein that is upregulated upon αCD3/αGITR stimulation, referred to as T-sTNF. Both patents disclose proteins, antibodies, activated T cells, and methods for utilizing these innovations in immune regulation.
Career Highlights
Sergio Quezada is affiliated with Dartmouth College, where he continues to advance research in immunology. His work has garnered attention for its potential applications in enhancing T cell immunity, which is crucial for developing new therapies for various diseases.
Collaborations
Quezada collaborates with esteemed colleagues, including Randolph J Noelle and Li-Fan Lu. Their combined expertise contributes to the innovative research being conducted at Dartmouth College.
Conclusion
Sergio Quezada's contributions to the field of immunology through his patents and research at Dartmouth College highlight his role as a significant inventor. His work on regulatory T cell proteins is paving the way for future advancements in immune therapies.